Actelion to discuss third quarter 2010 financial results
(Thomson Reuters ONE) -
Actelion Pharmaceuticals Ltd /
Actelion to discuss third quarter 2010 financial results
Processed and transmitted by Thomson Reuters.
The issuer is solely responsible for the content of this announcement.
Dear member of the investment community
Actelion Ltd will announce the third quarter 2010 financial results on Thursday,
21 October 2010, at 07.00 hrs CEST / 06.00 hrs BST / 01.00 a.m. EDT. An investor
conference call & webcast will be held at 14.00 hrs, CEST to discuss the
results.
Date/Time:
21 October 2010 14.00 hrs - 15.00 hrs Basel (CET)
13.00 hrs - 14.00 hrs UK (GMT)
08.00 a.m. - 09.00 a.m. US (EST)
Conference Call Connect #:
Dial-in participants should start calling the number below 10-15 minutes before
the conference is due to start.
Dial: Europe: +41 (0)44 580 64 03
UK: +44 (0)203 147 47 52
US: +1 866 931 1572
Participant's mode:
Listen-Only with possibility to open individual lines during Q&A session.
Participants will be asked for their Name and Company.
Webcast Access:
Webcast participants should visit the Actelion websitehttp://www.actelion.com/
10-15 minutes before the conference is due to start. If you experience any
access problems go directly to the URL:
http://gaia.world-television.com/actelion/20101021/trunc
Participant's mode:
Listen-Only with possibility to ask individual questions by clicking on the Q&A
button.
Participants will be asked to provide their Name and Company.
Webcast Replay:
The archived Investor Webcast will be available for replay
throughhttp://www.actelion.com/
approximately 60 minutes after the call has ended.
[HUG#1452702]
--- End of Message ---
Actelion Pharmaceuticals Ltd
Gewerbestrasse 16 Allschwil Switzerland
ISIN: CH0010532478;
Invitation:
http://hugin.info/131801/R/1452702/393421.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Actelion Pharmaceuticals Ltd via Thomson Reuters ONE
Unternehmensinformation / Kurzprofil:
Datum: 18.10.2010 - 17:36 Uhr
Sprache: Deutsch
News-ID 45862
Anzahl Zeichen: 0
contact information:
Town:
Allschwil
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 194 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Actelion to discuss third quarter 2010 financial results"
steht unter der journalistisch-redaktionellen Verantwortung von
Actelion Pharmaceuticals Ltd (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
